Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara A Ray

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
Drug and Alcohol Dependence|June 27, 2021
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokersErica N Grodin, Elizabeth M Burnette, ReJoyce Green, et al.
Psychopharmacology|January 28, 2026
Peripheral inflammation mediates the relationship between early life stress and alcohol useKaitlin R McManus, Craig Enders, Dylan E Kirsch, et al.
Alcoholism, Clinical and Experimental Research|September 8, 2011
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical reviewLara A Ray, Christina S Barr, Julie A Blendy, et al.
Psychopharmacology|April 16, 2014
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findingsLara A Ray, Kelly E Courtney, Dara G Ghahremani, et al.
Journal of Studies on Alcohol and Drugs|August 17, 2013
Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratoryKelly E Courtney, James Ashenhurst, Guadalupe Bacio, et al.
The American Journal of Drug and Alcohol Abuse|June 21, 2014
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findingsLara A Ray, Kelly E Courtney, Dara G Ghahremani, et al.
The American Journal of Drug and Alcohol Abuse|October 25, 2022
Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary studyErica N Grodin, Lindsay R Meredith, Elizabeth M Burnette, et al.
The American Journal on Addictions|July 10, 2008
Effects of naltrexone during the descending limb of the blood alcohol curveLara A Ray, Kent E Hutchison, James MacKillop, et al.
Psychopharmacology|February 9, 2025
Influence of real-world cue exposure and mood states on drinking: testing neurobiological models of alcohol use disorderLindsay R Meredith, Wave-Ananda Baskerville, Carrie Lee, et al.
The American Journal on Addictions|May 9, 2008
Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorderAdam M Leventhal, Christopher W Kahler, Lara A Ray, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
Drug and Alcohol Dependence|June 27, 2021
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokersErica N Grodin, Elizabeth M Burnette, ReJoyce Green, et al.
Psychopharmacology|January 28, 2026
Peripheral inflammation mediates the relationship between early life stress and alcohol useKaitlin R McManus, Craig Enders, Dylan E Kirsch, et al.
Alcoholism, Clinical and Experimental Research|September 8, 2011
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical reviewLara A Ray, Christina S Barr, Julie A Blendy, et al.
Psychopharmacology|April 16, 2014
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findingsLara A Ray, Kelly E Courtney, Dara G Ghahremani, et al.
Journal of Studies on Alcohol and Drugs|August 17, 2013
Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratoryKelly E Courtney, James Ashenhurst, Guadalupe Bacio, et al.
The American Journal of Drug and Alcohol Abuse|June 21, 2014
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findingsLara A Ray, Kelly E Courtney, Dara G Ghahremani, et al.
The American Journal of Drug and Alcohol Abuse|October 25, 2022
Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary studyErica N Grodin, Lindsay R Meredith, Elizabeth M Burnette, et al.
The American Journal on Addictions|July 10, 2008
Effects of naltrexone during the descending limb of the blood alcohol curveLara A Ray, Kent E Hutchison, James MacKillop, et al.
Psychopharmacology|February 9, 2025
Influence of real-world cue exposure and mood states on drinking: testing neurobiological models of alcohol use disorderLindsay R Meredith, Wave-Ananda Baskerville, Carrie Lee, et al.
The American Journal on Addictions|May 9, 2008
Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorderAdam M Leventhal, Christopher W Kahler, Lara A Ray, et al.
Pageof 29